Therapeutic Vaccine Market Growth Propelled by Chronic Illness

img

Rising incidences of various chronic illnesses such as cancer, HIV and cardiovascular diseases, innovative and effective vaccines present in the healthcare industry and increasing government funding for vaccine development are some of the factors proliferating the demand for therapeutic vaccine, as per the market research report from IndustryARC. The report has assessed the global therapeutic vaccine market valued $19.62 billion in 2018. Furthermore, the market is projected to increase at a CAGR of 36.52% during the forecast period 2019-2025.

The report is titled “Therapeutic Vaccine Market: By Vaccine Type (Addiction, Neurological, Infectious, and Autoimmune); By Technology (Autologous, Allogenic) and By Region – Forecast (2019-2025).” It consolidates an in-depth analysis of the imperative aspects of the market including market drivers, market value chain, restraints, growth indicators, market trends, challenges, future outlook, and market insights.

View Full Table Of Content Of Therapeutic Vaccine Market :

https://www.industryarc.com/Report/16292/therapeutic-vaccine-market.html

Therapeutic Vaccine Market: Leading Segments
North America constitutes a dominant regional share accounted for 46% of the global market in 2018. Growing initiatives by healthcare centers, improving recommended immunization, rising adoption of advanced technology in healthcare, improved infrastructure, and increasing healthcare expenditure are some important factors that have rendered North America with maximum demand share in the therapeutic vaccine market.

The therapeutic vaccine market is segmented on the basis of type into addiction vaccines, autoimmune disease vaccines, cancer vaccines, infectious disease vaccines, neurological disease vaccines, and Parkinson’s disease vaccines. Among these, autoimmune disease vaccines are found to be the major application segment. As per the recent studies by the American Autoimmune Related Diseases Association, autoimmune diseases are affecting nearly 50 million Americans, boosting the usage of autoimmune disease vaccine for treatment. Resultantly, key market players have capitalized on this application segment which is expected to grow with a CAGR of 18% through to 2025.

Also Read:  Global High-Temperature Coatings market is projected to reach 5030 Million US$ by 2025, at a CAGR of 4.4%

Therapeutic Vaccine Market Disruptive Trends
Certain number of innovative technologies are being developed in accordance with the development of new vaccines. Some of the latest disruptive trends are listed below:

·Single injection systems with a self-locking syringe:
It is designed to limit the problem of the reutilization of needles. This technology simplifies intradermal injection by using a small needle than a conventional one. Furthermore, patches comprising a set of micro-needles also used for intradermal injection are currently under development. Single injection systems with self-locking syringe technology is dominating the therapeutic vaccine market.

·Jet Injector:
As per the studies of Clinical, Cosmetic and Investigational Dermatology (CCID), the jet injector is gaining momentum in the therapeutic vaccine market. All safety concerns associated with needles are eliminated by jet injectors as vaccines are injected using gas or air pressurized systems.

·Nasal Vaccine:
The therapeutic vaccine market has been disrupted by the development of alternate administration routes namely nasal, intranasal, oral, topical, pulmonary, vaginal, and rectal. The nasal route offers the most promising opportunity for vaccine administration. It amplifies safety, convenience and elicits both local and systemic immune responses, therefore providing protection from pathogens while vaccination.

Therapeutic Vaccine Market: Competitive Landscape
Major companies currently holding majority or market share in the global therapeutic vaccine market are themare Cytos Biotechnology AG, Agenus, Inc., Pfizer, Merck & Co., Dendreon Corp., GlaxoSmithKline, Biocon, Argos Therapeutic Inc., Novartis AG, and Celtic Pharma.

Talk to one of our sales representative about the full report by providing your details in the link below:
https://industryarc.com/support.php?id= 16292

Related Reports:
A. DNA Vaccines Market
https://industryarc.com/Report/16032/dna-vaccines-market.html

B. Veterinary Vaccines Market
https://industryarc.com/PressRelease/881/Veterinary-Vaccines-Market-Research.html

What can you expect from the report?
The Therapeutic Vaccine Market is Prepared with the Main Agenda to Cover the following 20 points:
1. Therapeutic Vaccine Market Size by Product Categories & Application
2. Therapeutic Vaccine Market trends & Relevant Market Data
3. Manufacturer Landscape
4. Distributor Landscape
5. Pricing Analysis
6. Top 10 End-user Analysis
7. Product Benchmarking
8. Product Developments
9. Mergers & Acquisition Analysis
10. Patent Analysis
11. Therapeutic Vaccine Market Demand Analysis (Revenue & Volume)
12. Country-level Analysis
13. Competitor Analysis
14. Therapeutic Vaccine Market Shares Analysis
15. Value Chain Analysis
16. Supply Chain Analysis
17. Therapeutic Vaccine Market Strategic Analysis
18. Therapeutic Vaccine Market Current & Future Market Landscape Analysis
19. Opportunity Analysis
20. Therapeutic Vaccine Market Revenue and Volume Analysis

Also Read:  Global Electric Smoking System Market Significant Growth Foreseen by During 2019-2025

 

Q. Does IndustryARC provide customized reports and charge additionally for limited customization?
Response: Yes, we can customize the report by extracting data from our database of reports and annual subscription databases. We can provide the following free customization:
1. Increase the level of data in the application or end-user industry.

2. Increase the number of countries in geography chapter.

3. Find out market shares for other smaller companies or companies which are of interest to you.

4. Company profiles can be requested based on your interest.

5. Patent analysis, pricing, product analysis, product benchmarking, value and supply chain analysis can be requested for a country or end-use segment.

 

Any other custom requirements can be discussed with our team, drop an e-mail to sales@industryarc.com to discuss more our consulting services.

 

Media Contact:
Mr. Venkat Reddy
Sales Manager
Email 1: sales@industryarc.com
Or Email 2: venkat@industryarc.com
Contact Sales: +1-614-588-8538 (Ext-101)

About IndustryARC: IndustryARC is a research and consulting firm that publishes more than 500 reports annually, in various industries such as Agriculture, Automotive, Automation & Instrumentation, Chemicals and Materials, Energy and Power, Electronics, Food and Beverages, Information Technology, and Life sciences and Healthcare.

 

Email

Go to website